Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 9 min ago
Peer-reviewedLicence not statedChinese Journal of Cancer Research

Olaparib delays resolution of irreversible electroporation-induced DNA damage and enhances short-term antitumor activity in prostate cancer models

  • Jiacheng Xiang1
  • Zhiyu Xia1
  • Yuan Wang1
  • Shaogang Wang1
  • Qidong Xia1
  1. 1Department and Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Read full textDOICite

Related

  1. Association of irreversible electroporation treatment with overall survival in Stage III pancreatic ductal adenocarcinoma: DIRECT registry results
    Robert C G Martin II, Rebekah Ruth White, Malcolm M Bilimoria +9
    The OncologistPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Oncological and functional outcomes of focal irreversible electroporation for localised prostate cancer: a single institution series of 171 cases
    Z. Mian, T. Gianduzzo, B. Kua +1
    Prostate Cancer and Prostatic DiseasesPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  3. Combined anti-PD-1 with irreversible electroporation relieves immunosuppression and reduces hepatocellular carcinoma regrowth
    Jihui Huo, Lina Wang, Kai Lei +17
    JHEP ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  4. PGG Enhances Olaparib Efficacy via cGAS-STING Signaling and Sensitizes Triple-Negative Breast Cancer to PD- L1 Blockade
    h. S. Liu, X. Li, c. X. Yang +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  5. Metabolic engineering of Salmonella enterica for coupled kynurenine sensing and depletion enhances antitumor efficacy
    K. K. Varsha, A. Santos, T. Xiao +11
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv

Cite

BibTeXRIS
BibTeX
@article{xiang2026olaparib,
  title = {{Olaparib delays resolution of irreversible electroporation-induced DNA damage and enhances short-term antitumor activity in prostate cancer models}},
  author = {Jiacheng Xiang and Zhiyu Xia and Yuan Wang and Shaogang Wang and Qidong Xia},
  journal = {Chinese Journal of Cancer Research},
  year = {2026},
  month = oct,
  doi = {10.21147/j.issn.1000-9604.2026.05.10},
  url = {https://doi.org/10.21147/j.issn.1000-9604.2026.05.10},
}
RIS
TY  - JOUR
TI  - Olaparib delays resolution of irreversible electroporation-induced DNA damage and enhances short-term antitumor activity in prostate cancer models
AU  - Jiacheng Xiang
AU  - Zhiyu Xia
AU  - Yuan Wang
AU  - Shaogang Wang
AU  - Qidong Xia
PY  - 2026
DA  - 2026/10/30
JO  - Chinese Journal of Cancer Research
DO  - 10.21147/j.issn.1000-9604.2026.05.10
UR  - https://doi.org/10.21147/j.issn.1000-9604.2026.05.10
SN  - 1000-9604
SN  - 1993-0631
ER  -